Rose Vice President, Corporate Communications Avient Corporation +1 440-930-3162 kyle.rose@avient.com mailto:giuseppe.disalvo@avient.com mailto:kyle.rose@avient.com 5 Attachment 1 Avient Corporation Summary of Condensed Consolidated Statements of Income (Unaudited) (In millions, except per share data) Three Months Ended March 31, 2022 2021 Sales $ 1,293.8 $ 1,162.3 Operating Income 128.6 120.4 Net income attributable to Avient shareholders 84.2 79.3 Basic earnings per share attributable to Avient shareholders $ 0.92 $ 0.87 Diluted earnings per share attributable to Avient shareholders $ 0.91 $ 0.86 Senior management uses comparisons of adjusted net income attributable to Avient shareholders and diluted adjusted earnings per share (EPS) attributable to Avient shareholders, excluding special items, to assess performance and facilitate comparability of results. Three Months Ended March 31, 2022 2021 Sales: Color, Additives and Inks $ 649.5 $ 609.3 Specialty Engineered Materials 244.7 216.5 Distribution 432.9 362.7 Corporate and eliminations (33.3) (26.2) Sales $ 1,293.8 $ 1,162.3 Gross margin: Color, Additives and Inks $ 192.1 $ 197.5 Specialty Engineered Materials 69.8 64.7 Distribution 39.3 39.3 Corporate and eliminations (7.5) 0.9 Gross margin $ 293.7 $ 302.4 Selling and administrative expense: Color, Additives and Inks $ 97.6 $ 108.7 Specialty Engineered Materials 30.1 30.5 Distribution 15.1 15.3 Corporate and eliminations 22.3 27.5 Selling and administrative expense $ 165.1 $ 182.0 Operating income: Color, Additives and Inks $ 94.5 $ 88.8 Specialty Engineered Materials 39.7 34.2 Distribution 24.2 24.0 Corporate and eliminations (29.8) (26.6) Operating income $ 128.6 $ 120.4 Earnings before interest, taxes, depreciation and amortization (EBITDA): Color, Additives and Inks $ 120.5 $ 116.2 Specialty Engineered Materials 47.5 42.0 Distribution 24.4 24.2 Corporate and eliminations (26.0) (24.9) Other income, net (0.6) 1.5 EBITDA $ 165.8 $ 159.0 11 Attachment 7 Avient Corporation Reconciliation of Non-GAAP Financial Measures (Unaudited) (In millions, except per share data) Senior management uses gross margin before special items and operating income before special items to assess performance and allocate resources because senior management believes that these measures are useful in understanding current profitability levels and how it may serve as a basis for future performance. Three Months Ended March 31, 2022 2021 GAAP Results Special Items Adjusted Results GAAP Results Special Items Adjusted Results $111.1 $ 7.7 $ 118.8 $102.6 $ 2.4 $ 105.0 Income tax expense - GAAP (26.6) — (26.6) (22.9) — (22.9) Income tax impact of special items (Attachment 3) — (2.0) (2.0) — (0.9) (0.9) Tax adjustments (Attachment 3) — 1.5 1.5 — 1.1 1.1 Income tax (expense) benefit $ (26.6) $ (0.5) $ (27.1) $ (22.9) $ 0.2 $ (22.7) Effective Tax Rate(1) 23.9 % 22.8 % 22.3 % 21.6 % (1) Rates may not recalculate from figures presented herein due to rounding 12 Reconciliation of EBITDA by Segment Three Months Ended March 31, 2022 2021 Operating income: Color, Additives and Inks $ 94.5 $ 88.8 Specialty Engineered Materials 39.7 34.2 Distribution 24.2 24.0 Corporate and eliminations (29.8) (26.6) Operating income $ 128.6 $ 120.4 Items below OI in Corporate: Other income, net $ (0.6) $ 1.5 Depreciation & amortization: Color, Additives and Inks $ 26.0 $ 27.4 Specialty Engineered Materials 7.8 7.8 Distribution 0.2 0.2 Corporate and eliminations 3.8 1.7 Depreciation & Amortization $ 37.8 $ 37.1 EBITDA: Color, Additives and Inks $ 120.5 $ 116.2 Specialty Engineered Materials 47.5 42.0 Distribution 24.4 24.2 Corporate and eliminations (26.0) (24.9) Other income, net (0.6) 1.5 EBITDA $ 165.8 $ 159.0 EBITDA as a % of Sales: Color, Additives and Inks 18.6 % 19.1 % Specialty Engineered Materials 19.4 % 19.4 % Distribution 5.6 % 6.7 % Three Months Ended March 31, Reconciliation to EBITDA and Adjusted EBITDA: 2022 2021 Net income from continuing operations – GAAP $ 84.5 $ 79.7 Income tax expense 26.6 22.9 Interest expense 16.9 19.3 Depreciation and amortization 37.8 37.1 EBITDA $ 165.8 $ 159.0 Special items, before tax 7.7 2.4 Depreciation and amortization included in special items (2.1) (0.5) Adjusted EBITDA $ 171.4 $ 160.9 NEWS RELEASE Attachment 1

Polymer Colorants Mevopur™ Polymer Colorants and Additives Discover how our polymer colorants and additives can bring healthcare to life.

Chemically resistant polymers to protect against harsh medical-grade cleaners and disinfectants  Polymer Colorants Chemically Resistant Polymers for Next-Generation Devices

Polymer Colorants Mevopur™ Colorants and Additives - Healthcare Polymer Solutions Mevopur™ Polymer Colorants and Additives

Garratt Senior Vice President, President, Color, Additives and Inks, EMEA Joel R. Garratt Senior Vice President, President, Color, Additives and Inks, EMEA Joel R. Eastman Chemical Company RPM International Inc.

Increasing Effectiveness and Safety Avient’s range of medical-grade polymers, colorants, and additives can enhance the safety and effectiveness of these devices while helping manufacturers mitigate risks when bringing products to market. Avient’s portfolio of healthcare colorants includes standard and customized color solutions for a variety of polymers, from polyolefins, PC, PEBA, ABS, and styrenics to high temperature polysulfone resins.

Polymer Colorants Learn more about how Avient's medical-grade polymers, colorants and additives can enhance effectiveness and safety. Drop-in colorants and additives based on bio-polymers for the regulated healthcare market

Colorants & Additives This portfolio includes the recent addition of Mevopur bio-based polymer solutions, which are color and additive masterbatches based on bio-polyethylene resins that have up to 95 percent bio-based content. Trilliant™ HC8900 Thermoplastics are chemically resistant polymers that offer improved resistance to harsh chemicals and hospital-grade disinfectants compared to other flame-resistant (FR) polymers such as PC/ABS, PC/PET, and copolyester.

Mevopur™ Healthcare Bio-based Polymer Solutions Colorant and functional additive solutions formulated with bio-based polymers to reduce the carbon footprint of medical plastics. Antimicrobial corrosion and chemical resistant formulations to solve your medical application challenges

Polymer Colorants Mevopur™ Colorants and Additives - Healthcare Polymer Solutions Resist Chemical Attack